menu
    • menu

    Company profile for Immunitas Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering. IMT-009, a first-in-class T & NK cell modulator targeting CD161, is being developed for the treatment of solid tumors...
    Immunitas is an immuno-oncology therapeutics company advancing multiple programs to the clinic. Immunitas’ programs are derived from a cross-functional, highly integrated, single cell genomics platform that enables rapid target identification and validation in parallel with antibody discovery and engineering. IMT-009, a first-in-class T & NK cell modulator targeting CD161, is being developed for the treatment of solid tumors and hematological malignancies. The company was founded with leading scientists from Dana Farber, MGH, the Broad, and MIT. In 2019, Immunitas raised a $39M Series

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immunitas TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    830 Winter St., 2nd floor Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunitastx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunitas/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunitas Presents IMT-380 Preclinical Data at FASEB
    Immunitas Presents IMT-380 Preclinical Data at FASEB

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunitas-therapeutics-presents-preclinical-data-on-imt-380-a-first-in-class-anti-cd161-antibody-at-faseb-science-research-conference-on-autoimmunity-302516527.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    Immunitas Therapeutics Presents Data at the AACR 2024 Annual Meeting
    Immunitas Therapeutics Presents Data at the AACR 2024 Annual Meeting

    08 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunitas-therapeutics-presents-preclinical-data-supporting-combination-of-imt-009-with-anti-pd1-immunotherapy-at-the-aacr-2024-annual-meeting-302109948.html

    PR NEWSWIRE
    08 Apr 2024
    Share Share
    Immunitas to Present Preclinical Data Supporting Combination of IMT-009
    Immunitas to Present Preclinical Data Supporting Combination of IMT-009

    05 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunitas-therapeutics-to-present-preclinical-data-supporting-combination-of-imt-009-with-anti-pd1-immunotherapy-at-the-aacr-2024-annual-meeting-302080492.html

    PR NEWSWIRE
    05 Mar 2024
    Share Share
    Immunitas Appoints Annalisa D'Andrea, Ph.D., as Chief Scientific Officer
    Immunitas Appoints Annalisa D'Andrea, Ph.D., as Chief Scientific Officer

    18 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunitas-therapeutics-appoints-annalisa-dandrea-phd-as-chief-scientific-officer-302037891.html

    PR NEWSWIRE
    18 Jan 2024
    Share Share
    Immunitas Therapeutics Announces Appointment of James Wooldridge as CMO
    Immunitas Therapeutics Announces Appointment of James Wooldridge as CMO

    04 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunitas-therapeutics-announces-appointment-of-james-wooldridge-as-chief-medical-officer-and-upcoming-presentation-at-ash-2023-annual-meeting-302003773.html

    PR NEWSWIRE
    04 Dec 2023
    Share Share
    Immunitas Therapeutics Presents New Data for TLR9 Agonist Conjugate
    Immunitas Therapeutics Presents New Data for TLR9 Agonist Conjugate

    03 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunitas-therapeutics-presents-new-data-for-tlr9-agonist-conjugate-at-the-society-for-immunotherapy-of-cancer-2023-annual-meeting-301976730.html

    PR NEWSWIRE
    03 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search